Literature DB >> 28478517

Anti-inflammatory Effects of Valproic Acid in a Rat Model of Renal Ischemia/Reperfusion Injury: Alteration in Cytokine Profile.

Mohammad Ali Amirzargar1, Faramarz Yaghubi1, Mohammad Hosseinipanah2, Mohammad Jafari3, Mona Pourjafar4, Mahsa Rezaeepoor4, Hamzeh Rezaei4, Godratollah Roshanaei5, Mehrdad Hajilooi4, Ghasem Solgi6.   

Abstract

Valporic acid (VPA) has been implicated to have anti-inflammatory and anti-oxidant activities in several ischemic/reperfusion (I/R) injury models. This study intended to evaluate whether VPA could affect the inflammatory/anti-inflammatory cytokines balance and severity of renal I/R injury in rat. I/R injury was induced in two groups of animals, vehicle normal saline and VPA-treated (IP injection, 150 mg/kg) rats, by 45 min occlusion of both left and right renal arteries followed by 3, 24 and 120 h reperfusion in separate groups. After each time point, kidneys and blood samples were collected for cytokine genes (TNF-α, IL-1β, IL-10 and TGF-β) expression analysis and histological examinations in the kidney tissues. Serum creatinine levels were measured for evaluation of renal function. We observed significantly downregulated mRNA expressions for IL-1β and TNF-α in blood and tissue samples 24 and 120 h post I/R injury in VPA-treated animals compared to control groups (P < 0.0001). On the other hand, mRNA expression levels for IL-10 and TGF-β were significantly increased in the blood samples from VPA-treated animals at two time points after I/R injury (P < 0.0001) and at 120 h in tissue samples (P < 0.001). Histopathology analysis showed downgraded ischemic changes in VPA group compared to sham control. Also, decreased serum creatinine levels were observed in VPA-treated animals particularly 120 h post I/R injury (P < 0.0001) that was correlated with less pathological changes in this group. Our results indicate that VPA can attenuate pro-inflammatory responses and augment the anti-inflammatory condition in favor of faster renal recovery from ischemic changes and improved renal function after renal I/R injury.

Entities:  

Keywords:  interleukin-10; interleukin-1β; renal ischemia/reperfusion; transforming growth factor-β; tumor necrosis factor-α; valproic acid

Mesh:

Substances:

Year:  2017        PMID: 28478517     DOI: 10.1007/s10753-017-0574-9

Source DB:  PubMed          Journal:  Inflammation        ISSN: 0360-3997            Impact factor:   4.092


  37 in total

1.  TGF-beta 1 attenuates myocardial ischemia-reperfusion injury via inhibition of upregulation of MMP-1.

Authors:  Hongjiang Chen; Dayuan Li; Tom Saldeen; Jawahar L Mehta
Journal:  Am J Physiol Heart Circ Physiol       Date:  2003-05       Impact factor: 4.733

2.  Medullary plasma flow and intravascular leukocyte accumulation in acute renal failure.

Authors:  K Solez; E C Kramer; J A Fox; R H Heptinstall
Journal:  Kidney Int       Date:  1974-07       Impact factor: 10.612

3.  Valproic acid defines a novel class of HDAC inhibitors inducing differentiation of transformed cells.

Authors:  M Göttlicher; S Minucci; P Zhu; O H Krämer; A Schimpf; S Giavara; J P Sleeman; F Lo Coco; C Nervi; P G Pelicci; T Heinzel
Journal:  EMBO J       Date:  2001-12-17       Impact factor: 11.598

4.  Interleukin-10 inhibits ischemic and cisplatin-induced acute renal injury.

Authors:  J Deng; Y Kohda; H Chiao; Y Wang; X Hu; S M Hewitt; T Miyaji; P McLeroy; B Nibhanupudy; S Li; R A Star
Journal:  Kidney Int       Date:  2001-12       Impact factor: 10.612

5.  Valproic acid attenuates ischemia-reperfusion injury in the rat brain through inhibition of oxidative stress and inflammation.

Authors:  Satoshi Suda; Ken-ichiro Katsura; Takuya Kanamaru; Moeko Saito; Yasuo Katayama
Journal:  Eur J Pharmacol       Date:  2013-03-26       Impact factor: 4.432

6.  Regulatory effects of interleukin-10 on lung ischemia-reperfusion injury.

Authors:  M J Eppinger; P A Ward; S F Bolling; G M Deeb
Journal:  J Thorac Cardiovasc Surg       Date:  1996-11       Impact factor: 5.209

7.  Major Ozonated Autohemotherapy Preconditioning Ameliorates Kidney Ischemia-Reperfusion Injury.

Authors:  Eyup Burak Sancak; Hakan Turkön; Selma Çukur; Sevilay Erimsah; Alpaslan Akbas; Murat Tolga Gulpinar; Huseyin Toman; Hasan Sahin; Metehan Uzun
Journal:  Inflammation       Date:  2016-02       Impact factor: 4.092

8.  Foxp3+ regulatory T cells participate in repair of ischemic acute kidney injury.

Authors:  Maria Teresa Gandolfo; Hye Ryoun Jang; Serena M Bagnasco; Gang-Jee Ko; Patricia Agreda; Shailesh R Satpute; Michael T Crow; Landon S King; Hamid Rabb
Journal:  Kidney Int       Date:  2009-07-22       Impact factor: 10.612

9.  Gender-specific behavioral and immunological alterations in an animal model of autism induced by prenatal exposure to valproic acid.

Authors:  Tomasz Schneider; Adam Roman; Agnieszka Basta-Kaim; Marta Kubera; Bogusława Budziszewska; Karolina Schneider; Ryszard Przewłocki
Journal:  Psychoneuroendocrinology       Date:  2008-04-08       Impact factor: 4.905

10.  Effects of valproic acid and dexamethasone administration on early bio-markers and gene expression profile in acute kidney ischemia-reperfusion injury in the rat.

Authors:  Ryan W Speir; Jonathan D Stallings; Jared M Andrews; Mary S Gelnett; Timothy C Brand; Shashikumar K Salgar
Journal:  PLoS One       Date:  2015-05-13       Impact factor: 3.240

View more
  14 in total

Review 1.  Beyond the brain: A multi-system inflammatory subtype of autism spectrum disorder.

Authors:  Robyn P Thom; Christopher J Keary; Michelle L Palumbo; Caitlin T Ravichandran; Jennifer E Mullett; Eric P Hazen; Ann M Neumeyer; Christopher J McDougle
Journal:  Psychopharmacology (Berl)       Date:  2019-05-28       Impact factor: 4.530

2.  Relationships between low-grade peripheral inflammation and psychotropic drugs in schizophrenia: results from the national FACE-SZ cohort.

Authors:  G Fond; N Resseguier; F Schürhoff; O Godin; M Andrianarisoa; L Brunel; E Bulzacka; B Aouizerate; F Berna; D Capdevielle; I Chereau; T D'Amato; C Dubertret; J Dubreucq; C Faget; F Gabayet; C Lançon; P M Llorca; J Mallet; D Misdrahi; C Passerieux; R Rey; A Schandrin; M Urbach; P Vidailhet; L Boyer; M Leboyer
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2017-11-10       Impact factor: 5.270

3.  Class IIa HDAC inhibitor TMP195 alleviates lipopolysaccharide-induced acute kidney injury.

Authors:  Wei Zhang; Yinjie Guan; George Bayliss; Shougang Zhuang
Journal:  Am J Physiol Renal Physiol       Date:  2020-10-05

4.  Valproic acid restores the down-regulation of SDF-1 following kidney ischemia; experimental validation of a mathematical prediction.

Authors:  Kobra Moradzadeh; Seyed Mahdi Nassiri; Yousof Gheisari
Journal:  Res Pharm Sci       Date:  2020-05-11

Review 5.  Histone Deacetylase Inhibitors: A Novel Strategy for Neuroprotection and Cardioprotection Following Ischemia/Reperfusion Injury.

Authors:  Zachary Pickell; Aaron M Williams; Hasan B Alam; Cindy H Hsu
Journal:  J Am Heart Assoc       Date:  2020-05-22       Impact factor: 5.501

6.  Intestinal inflammation increases convulsant activity and reduces antiepileptic drug efficacy in a mouse model of epilepsy.

Authors:  Carmen De Caro; Antonio Leo; Valentina Nesci; Carla Ghelardini; Lorenzo di Cesare Mannelli; Pasquale Striano; Carmen Avagliano; Antonio Calignano; Paolo Mainardi; Andrew Constanti; Rita Citraro; Giovambattista De Sarro; Emilio Russo
Journal:  Sci Rep       Date:  2019-09-27       Impact factor: 4.379

7.  Systematic review and meta-analysis of experimental studies evaluating the organ protective effects of histone deacetylase inhibitors.

Authors:  Syabira I Yusoff; Marius Roman; Florence Y Lai; Bryony Eagle-Hemming; Gavin J Murphy; Tracy Kumar; Marcin Wozniak
Journal:  Transl Res       Date:  2018-11-22       Impact factor: 10.171

8.  Valproic acid exerts specific cellular and molecular anti-inflammatory effects in post-operative conjunctiva.

Authors:  Li-Fong Seet; Li Zhen Toh; Sharon N Finger; Stephanie W L Chu; Tina T Wong
Journal:  J Mol Med (Berl)       Date:  2018-11-19       Impact factor: 4.599

9.  Evaluation of serum high-mobility group box 1 concentration in dogs with epilepsy: A case-control study.

Authors:  Yoonhoi Koo; Hakhyun Kim; Taesik Yun; Dong-In Jung; Ji-Houn Kang; Dongwoo Chang; Ki-Jeong Na; Mhan-Pyo Yang; Byeong-Teck Kang
Journal:  J Vet Intern Med       Date:  2020-11-05       Impact factor: 3.333

10.  Valproic acid inhibits interferon-γ production by NK cells and increases susceptibility to Listeria monocytogenes infection.

Authors:  Rodolfo Soria-Castro; Alma D Chávez-Blanco; Blanca Estela García-Pérez; Isabel Wong-Baeza; Raúl Flores-Mejía; Fabián Flores-Borja; Sergio Estrada-Parra; Iris Estrada-García; Jeanet Serafín-López; Rommel Chacón-Salinas
Journal:  Sci Rep       Date:  2020-10-20       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.